Cargando…
High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone
BACKGROUND: Lymphatic filariasis elimination programs are based upon preventative chemotherapy annually in populations with prevalence more than or equal to 1%. The goal is to treat 80% of the eligible, at risk population yearly, for at least 5 years, in order to interrupt transmission and prevent c...
Autores principales: | Hodges, Mary H, Smith, Samuel J, Fussum, Daniel, Koroma, Joseph B, Conteh, Abdul, Sonnie, Mustapha, Sesay, Santigie, Zhang, Yaobi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018440/ https://www.ncbi.nlm.nih.gov/pubmed/21162751 http://dx.doi.org/10.1186/1756-3305-3-120 |
Ejemplares similares
-
Progress on elimination of lymphatic filariasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2018) -
Impact of Three Rounds of Mass Drug Administration on Lymphatic Filariasis in Areas Previously Treated for Onchocerciasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2013) -
Maintaining effective mass drug administration for lymphatic filariasis through in-process monitoring in Sierra Leone
por: Hodges, Mary H, et al.
Publicado: (2012) -
Achievements and challenges of lymphatic filariasis elimination in Sierra Leone
por: Bah, Yakuba M., et al.
Publicado: (2020) -
Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2018)